Literature DB >> 23735121

Renal and mesenteric tissue oxygenation in preterm infants treated with oral ibuprofen.

Nilufer Guzoglu1, Fatma Nur Sari, Ramazan Ozdemir, Serife Suna Oguz, Nurdan Uras, Nahide Altug, Ugur Dilmen.   

Abstract

BACKGROUND: Hemodynamically significant patent ductus arteriosus (PDA) is a common problem in preterm infants which often causes significant morbidities. Although PDA induces alterations in various tissue perfusion, there is scarce information about the effect of oral ibuprofen on hemodynamics of regional tissues.
OBJECTIVE: To investigate, using near-infrared spectroscopy, the effect of oral ibuprofen on renal and mesenteric tissue oxygenation and oxygen extraction in preterm infants with a diagnosis of hemodynamically significant PDA. PATIENTS AND METHODS: Fifteen infants (gestational age <32 weeks) with the diagnosis of hemodynamically significant PDA treated with oral ibuprofen were monitored for near-infrared spectroscopy - determined renal and mesenteric oxygenation. The infants with PDA were matched for gestational age, postnatal age with infants without PDA, who served as control subjects.
RESULTS: In infants with PDA, mean arterial blood pressure was significantly lower compared with the control infants [39.3 (range:36-54) versus 51 (range:43-66) mmHg, respectively; p < 0.001)]. There were no significant differences in regional oxygen saturation and fractional oxygen extraction of renal and mesenteric tissues in PDA and control infants (p > 0.05). And ibuprofen treatment did not negatively influence renal and mesenteric oxygenation and extraction in infants with PDA (p > 0.05).
CONCLUSION: Renal and mesenteric tissue oxygenation and oxygen extraction were preserved in preterm infants with a diagnosis of hemodynamically significant PDA treated with oral ibuprofen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23735121     DOI: 10.3109/14767058.2013.811485

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  5 in total

Review 1.  Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus.

Authors:  Mehmet Yekta Oncel; Omer Erdeve
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 2.  Patent ductus arteriosus in preterm infants: do we have the right answers?

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  Biomed Res Int       Date:  2013-12-23       Impact factor: 3.411

Review 3.  Renal Tissue Oxygenation Monitoring-An Opportunity to Improve Kidney Outcomes in the Vulnerable Neonatal Population.

Authors:  Matthew W Harer; Valerie Y Chock
Journal:  Front Pediatr       Date:  2020-05-14       Impact factor: 3.418

Review 4.  Management of Patent Ductus Arteriosus in Premature Infants in 2020.

Authors:  Sarah Parkerson; Ranjit Philip; Ajay Talati; Shyam Sathanandam
Journal:  Front Pediatr       Date:  2021-02-11       Impact factor: 3.418

Review 5.  To Feed or Not to Feed: A Critical Overview of Enteral Feeding Management and Gastrointestinal Complications in Preterm Neonates with a Patent Ductus Arteriosus.

Authors:  Silvia Martini; Arianna Aceti; Silvia Galletti; Isadora Beghetti; Giacomo Faldella; Luigi Corvaglia
Journal:  Nutrients       Date:  2019-12-27       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.